Genmab — Januar 2020

[JKY_VH]

Jeg tænkte som bare på, hvad det kunne gøre for kursen pt. Pensionisten:-)

[Nike]

Trump har bombet mere end Irak. Folk er i panik og mon ikke vi skal se en politisk stabilitet, før man kan forholde sig med et minimum af fornuft til kursen. Den politiske uro kan vise sig at være mere giftig for de finansielle markeder end en handelskonflikt

[Peree]

Man har snart set dette så mange gange, så mon ikke det hele brager op om en uge, når folk stopper med at se rødt. Det er typisk der kommer en udmelding fra Trump og så daler det kortvarrigt. Ydermere, mon ikke JP morgan havde afventet at løfte kursmålet til 1700, hvis de mente der var fare på færde?

[StockBull]

Vi vi lander på 2.9 eller 3.1 mia giver vel ikke den forskel på kursen nu hvor vi skriver 2020 - kursen afspejler jo allerede 2.9 Vi mene det er 2020 guiding som afgør om vi skal vidre op mod de 1800 i første omgang og det helt stort ryk bliver hvis 2021 kommer i hus inden for konsensus og der skal vi vel from mod Q3 inden vi han danne os et realistisk billed

[StockBull]

Vi Vi = Om vi

[Mcjean]

Har du et link til folk i panik?

[Mcjean]

Eller er det bare globalistmedierne anført af det ræverøde slæng der løber med en halv vind og i deres frustration over ikke at kunne styre Trump oplever en kollektiv kognitiv dissonans!

[E_L]

article on ADCs https://www.reuters.com/article/us-cancer-adc-focus/drug-developers-take-fresh-aim-at-guided-missile-cancer-drugs-idUSKBN1Z510J

[gentogen]

Ikke helt ny, men vist nok ny her: Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. https://www.ncbi.nlm.nih.gov/pubmed/31600169

[gentogen]

EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab. In TT7, we introduced Dara during all phases of therapy, including immune consolidation early post ASCT, to improve responses rate and PFS in HRMM.

[gentogen]

The 1-yr cumulative incidence estimates for reaching VGPR and PR were 87 and 83%, respectively. A CR or sCR was achieved in 68 and 46%. The early results of TT7 point to increased response rates of HRMM to a dara-based TT regimen with especially higher rates of CR and sCR

[E_L]

Genmab to Present at the 38th Annual J.P. Morgan on January 15 -with webcast

[E_L]

by then Jan will know whether we breached the $3bn or not... so he can either glow about it, or do damage controll

[E_L]

if you are still interested in Ofatumumab in CLL - https://www.nature.com/articles/s41408-019-0260-2

[Bulder]

We'll also know by then. If we haven't heard anything - then we didn't get it.

[E_L]

i think so too, and then we'll hear the real number a week later, JNJ results 22nd

[Bulder]

28?

[Bulder]

no you are right -
22nd

[E_L]

funny, US, which started this Iran sh** starting to go green again... we are still 20kr down... must be because of all those Dara sales to Iran...?

[Solsen]

Lets hope we get an announcement the coming days....